Improved NanobodiesTM against Tumor Necrosis Factor-alpha

Details for Australian Patent Application No. 2006249144 (hide)

Owner Ablynx N.V.

Inventors Beirnaert, Els

Agent Spruson & Ferguson

Pub. Number AU-B-2006249144

PCT Pub. Number WO2006/122786

Priority 60/682,332 18.05.05 US

Filing date 17 May 2006

Wipo publication date 23 November 2006

Acceptance publication date 17 November 2011

International Classifications

C07K 16/18 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies - against material from animals or humans

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

C07K 16/24 (2006.01) Immunoglobulins, e.g. monoclonal or polyclonal antibodies

Event Publications

13 December 2007 PCT application entered the National Phase

  PCT publication WO2006/122786 Priority application(s): WO2006/122786

17 November 2011 Application Accepted

  Published as AU-B-2006249144

15 March 2012 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006249146-Derivatives of 4-(2-amino-1-hydroxyethyl)phenol as agonists of the beta2 adrenergic receptor

2006249141-Food temperature setting using RFID technology